Stop Wasting Time & Money Choosing The Wrong Biosimilar Product
The Problem
The complex and ever-changing factors that affect the biosimilar landscape can make it challenging for health systems to develop effective strategies for choosing the most profitable biosimilar for each patient.
Amplify Rx offers a solution by partnering with healthcare providers and health systems, providing them with our proprietary software that automates the selection of biosimilars at the patient level, leading to increased efficiency and improved margin.
Continually Evolving Product Competition
Biosimilars create new competition as each jockeys for marketplace share. Changing prices, rebates, payments, and product availability make it difficult to know which product to use for the right patient at the right time.
Dynamic
Payer Policies
Ever-changing payer policies add to the challenges of prescribing biosimilars. Uncertainty around payer coverages can result in delays in patient treatment and provider frustrations.
Outdated Formulary Processes
Relying on a single biosimilar workhorse or lowest cost product no longer works in a dynamic biosimilar marketplace.
Unrealized Financial Opportunity
Lack of transparency into payment rates and coverages leads to non optimized product selection and unrealized financial opportunities for providers.
The Solution
01
Real-time decision support
A tool that helps the authorization team quickly find the best biosimilar product for each patient, considering their insurance and the organization's procurement and reimbursement strategies.
03
Maximized financial opportunities
Enhance the experience for prescribers by avoiding unnecessary notifications about therapies that aren't covered, maximizing financial opportunities.
02
Streamlined authorization process
Boost efficiency by instantly knowing the best covered product for different insurance providers, making the authorization process smoother.
04
Improved payer policy management
Increase reimbursement for biosimilar or reference products by creating transparency into payer policies.
The Challenge:
Inova Case Study
Inova, like most US health systems, needed support keeping up with the frequency of changes within payer polices in the biosimilar space.
They were in search of a solution that improved the operational efficiency of their authorization process.
They needed a technology that allowed them to maximize financial opportunities in the biosimilar space.
Meet the Team
The founders of Amplify Rx have over 4 decades of combined experience in pharmacy.
Co-Founder
Matt Gibson
Matt is an established leader in healthcare with over 10 years experience in developing health care solutions. He brings a wealth of knowledge in biosimilar strategy, oncology practice, and innovative healthcare business models.
Co-Founder
Lisa Blanchette
With 10 years of health-system pharmacy experience, Lisa brings a detailed understanding of medication and revenue strategies for the infusion space. She also has expertise in specialty pharmacy programs and formulary management. Lisa is passionate about improving the patient and provider experience in healthcare delivery.
Co-Founder
Curtis Wander
Curtis has a detailed understanding of the managed care industry with a career background in the payer realm. He provides a deep understanding of biosimilar payer strategies as well a vast knowledge set in payer goals, tactics, and drivers across medical and pharmacy benefits.